Clinical Trial Update: The Effects of Intermittent Theta Burst Stimulation in MCI and Early AD [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intermittent theta burst stimulation for mild cognitive impairment and early Alzheimer’s disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Snippet

Sponsor: Taipei Medical University Shuang Ho Hospital | Conditions: Mild Cognitive Impairment, Alzheimer Disease | Phase 2 | Status: COMPLETED